Non-steroidal anti-inflammatory drug-induced gastric damage in experimental animals: Underlying pathological mechanisms
- 1 November 1995
- journal article
- review article
- Published by Elsevier in General Pharmacology: The Vascular System
- Vol. 26 (7) , 1455-1459
- https://doi.org/10.1016/0306-3623(95)00037-2
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- NS-398, a novel non-steroidal anti-inflammatory drug with potent analgesic and antipyretic effects, which causes minimal stomach lesionsPublished by Elsevier ,2002
- Sucrose: A novel permeability marker for gastroduodenal diseaseGastroenterology, 1993
- Enhanced gastric mucosal leukotriene B4 synthesis in patients taking non-steroidal anti-inflammatory drugs.Gut, 1993
- Prostaglandins inhibit inflammatory mediator release from rat mast cellsGastroenterology, 1993
- NSAID-Induced Gastrointestinal DamageJournal of Clinical Gastroenterology, 1990
- Nonsteroidal Antiinflammatory Drug-Induced Ulcers: Management by Traditional TherapiesGastroenterology, 1989
- Prevention of gastroduodenal damage induced by non-steroidal anti-inflammatory drugs: controlled trial of ranitidine.BMJ, 1988
- Effects of loxtidine, a new histamine H2-receptor antagonist, on 24-hour gastric secretion in manEuropean Journal of Clinical Pharmacology, 1984
- H2-receptor antagonists protect against aspirin-induced gastric lesions in the ratInflammation Research, 1981
- SOME in vitro AND in vivo ACTIONS OF THE NEW HISTAMINE H2‐RECEPTOR ANTAGONIST, RANITIDINEBritish Journal of Pharmacology, 1981